 | • レポートコード：MRC2-11QY13554 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は後天性孤児血液疾患のグローバル市場について調査・分析したレポートです。種類別（投薬、骨髄移植、輸血、鉄療法）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別後天性孤児血液疾患の競争状況、市場シェア ・世界の後天性孤児血液疾患市場：種類別市場規模 2015年-2020年（投薬、骨髄移植、輸血、鉄療法） ・世界の後天性孤児血液疾患市場：種類別市場規模予測 2021年-2026年（投薬、骨髄移植、輸血、鉄療法） ・世界の後天性孤児血液疾患市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界の後天性孤児血液疾患市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米の後天性孤児血液疾患市場分析：米国、カナダ ・ヨーロッパの後天性孤児血液疾患市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの後天性孤児血液疾患市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の後天性孤児血液疾患市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの後天性孤児血液疾患市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Acorno Acorns、Alexion Pharmaceuticals、Amgen、Celgene Corporation、Eli Lilly、Sanofi、GlaxoSmithKline、Cyclacel Pharmaceuticals、Onconova Therapeutics、Incyte Corporation、CTI BioPharma ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Acquired orphan blood disease is a type of rare blood disorder, which occurs due to the presence of insufficient amount of red blood cells in the blood. This disease is characterized by the body?s inability to produce red blood cells. Moreover, improper functioning of bone marrow also leads to lack of red blood cells in blood, which in turn results in a decrease in platelet numbers. This decrease in platelet number causes anemia and thrombosis.
Currently, North America dominates the global acquired orphan blood disease market, followed by Europe. This is due to the rising prevalence of blood related diseases and increasing R&D investment in these regions. In addition, increasing access to healthcare insurance, especially in the U.S., is also influencing the growth of the acquired orphan blood disease market in the region. Asia is expected to be the fastest growing market in the next five years. This is due to the rising healthcare infrastructure and increasing government initiatives for better healthcare facilities in this region. Moreover, the presence of a large patient population base is also driving the growth of the acquired orphan blood disease market in this region.
Market Analysis and Insights: Global Acquired Orphan Blood Disease Market
The global Acquired Orphan Blood Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Acquired Orphan Blood Disease Scope and Market Size
Acquired Orphan Blood Disease market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Acquired Orphan Blood Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Acorno Acorns
Alexion Pharmaceuticals
Amgen
Celgene Corporation
Eli Lilly
Sanofi
GlaxoSmithKline
Cyclacel Pharmaceuticals
Onconova Therapeutics
Incyte Corporation
CTI BioPharma
Market segment by Type, the product can be split into
Medication
Bone Marrow Transplant
Blood Transfusion
Iron Therapy
Market segment by Application, split into
Hospitals
Clinics
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Acquired Orphan Blood Disease Revenue
1.4 Market by Type
1.4.1 Global Acquired Orphan Blood Disease Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Medication
1.4.3 Bone Marrow Transplant
1.4.4 Blood Transfusion
1.4.5 Iron Therapy
1.5 Market by Application
1.5.1 Global Acquired Orphan Blood Disease Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Acquired Orphan Blood Disease Market Perspective (2015-2026)
2.2 Global Acquired Orphan Blood Disease Growth Trends by Regions
2.2.1 Acquired Orphan Blood Disease Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Acquired Orphan Blood Disease Historic Market Share by Regions (2015-2020)
2.2.3 Acquired Orphan Blood Disease Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Acquired Orphan Blood Disease Market Growth Strategy
2.3.6 Primary Interviews with Key Acquired Orphan Blood Disease Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Acquired Orphan Blood Disease Players by Market Size
3.1.1 Global Top Acquired Orphan Blood Disease Players by Revenue (2015-2020)
3.1.2 Global Acquired Orphan Blood Disease Revenue Market Share by Players (2015-2020)
3.1.3 Global Acquired Orphan Blood Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Acquired Orphan Blood Disease Market Concentration Ratio
3.2.1 Global Acquired Orphan Blood Disease Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Acquired Orphan Blood Disease Revenue in 2019
3.3 Acquired Orphan Blood Disease Key Players Head office and Area Served
3.4 Key Players Acquired Orphan Blood Disease Product Solution and Service
3.5 Date of Enter into Acquired Orphan Blood Disease Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Acquired Orphan Blood Disease Historic Market Size by Type (2015-2020)
4.2 Global Acquired Orphan Blood Disease Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Acquired Orphan Blood Disease Market Size by Application (2015-2020)
5.2 Global Acquired Orphan Blood Disease Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Acquired Orphan Blood Disease Market Size (2015-2020)
6.2 Acquired Orphan Blood Disease Key Players in North America (2019-2020)
6.3 North America Acquired Orphan Blood Disease Market Size by Type (2015-2020)
6.4 North America Acquired Orphan Blood Disease Market Size by Application (2015-2020)
7 Europe
7.1 Europe Acquired Orphan Blood Disease Market Size (2015-2020)
7.2 Acquired Orphan Blood Disease Key Players in Europe (2019-2020)
7.3 Europe Acquired Orphan Blood Disease Market Size by Type (2015-2020)
7.4 Europe Acquired Orphan Blood Disease Market Size by Application (2015-2020)
8 China
8.1 China Acquired Orphan Blood Disease Market Size (2015-2020)
8.2 Acquired Orphan Blood Disease Key Players in China (2019-2020)
8.3 China Acquired Orphan Blood Disease Market Size by Type (2015-2020)
8.4 China Acquired Orphan Blood Disease Market Size by Application (2015-2020)
9 Japan
9.1 Japan Acquired Orphan Blood Disease Market Size (2015-2020)
9.2 Acquired Orphan Blood Disease Key Players in Japan (2019-2020)
9.3 Japan Acquired Orphan Blood Disease Market Size by Type (2015-2020)
9.4 Japan Acquired Orphan Blood Disease Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Acquired Orphan Blood Disease Market Size (2015-2020)
10.2 Acquired Orphan Blood Disease Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Acquired Orphan Blood Disease Market Size by Type (2015-2020)
10.4 Southeast Asia Acquired Orphan Blood Disease Market Size by Application (2015-2020)
11 India
11.1 India Acquired Orphan Blood Disease Market Size (2015-2020)
11.2 Acquired Orphan Blood Disease Key Players in India (2019-2020)
11.3 India Acquired Orphan Blood Disease Market Size by Type (2015-2020)
11.4 India Acquired Orphan Blood Disease Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Acquired Orphan Blood Disease Market Size (2015-2020)
12.2 Acquired Orphan Blood Disease Key Players in Central & South America (2019-2020)
12.3 Central & South America Acquired Orphan Blood Disease Market Size by Type (2015-2020)
12.4 Central & South America Acquired Orphan Blood Disease Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Acorno Acorns
13.1.1 Acorno Acorns Company Details
13.1.2 Acorno Acorns Business Overview
13.1.3 Acorno Acorns Acquired Orphan Blood Disease Introduction
13.1.4 Acorno Acorns Revenue in Acquired Orphan Blood Disease Business (2015-2020))
13.1.5 Acorno Acorns Recent Development
13.2 Alexion Pharmaceuticals
13.2.1 Alexion Pharmaceuticals Company Details
13.2.2 Alexion Pharmaceuticals Business Overview
13.2.3 Alexion Pharmaceuticals Acquired Orphan Blood Disease Introduction
13.2.4 Alexion Pharmaceuticals Revenue in Acquired Orphan Blood Disease Business (2015-2020)
13.2.5 Alexion Pharmaceuticals Recent Development
13.3 Amgen
13.3.1 Amgen Company Details
13.3.2 Amgen Business Overview
13.3.3 Amgen Acquired Orphan Blood Disease Introduction
13.3.4 Amgen Revenue in Acquired Orphan Blood Disease Business (2015-2020)
13.3.5 Amgen Recent Development
13.4 Celgene Corporation
13.4.1 Celgene Corporation Company Details
13.4.2 Celgene Corporation Business Overview
13.4.3 Celgene Corporation Acquired Orphan Blood Disease Introduction
13.4.4 Celgene Corporation Revenue in Acquired Orphan Blood Disease Business (2015-2020)
13.4.5 Celgene Corporation Recent Development
13.5 Eli Lilly
13.5.1 Eli Lilly Company Details
13.5.2 Eli Lilly Business Overview
13.5.3 Eli Lilly Acquired Orphan Blood Disease Introduction
13.5.4 Eli Lilly Revenue in Acquired Orphan Blood Disease Business (2015-2020)
13.5.5 Eli Lilly Recent Development
13.6 Sanofi
13.6.1 Sanofi Company Details
13.6.2 Sanofi Business Overview
13.6.3 Sanofi Acquired Orphan Blood Disease Introduction
13.6.4 Sanofi Revenue in Acquired Orphan Blood Disease Business (2015-2020)
13.6.5 Sanofi Recent Development
13.7 GlaxoSmithKline
13.7.1 GlaxoSmithKline Company Details
13.7.2 GlaxoSmithKline Business Overview
13.7.3 GlaxoSmithKline Acquired Orphan Blood Disease Introduction
13.7.4 GlaxoSmithKline Revenue in Acquired Orphan Blood Disease Business (2015-2020)
13.7.5 GlaxoSmithKline Recent Development
13.8 Cyclacel Pharmaceuticals
13.8.1 Cyclacel Pharmaceuticals Company Details
13.8.2 Cyclacel Pharmaceuticals Business Overview
13.8.3 Cyclacel Pharmaceuticals Acquired Orphan Blood Disease Introduction
13.8.4 Cyclacel Pharmaceuticals Revenue in Acquired Orphan Blood Disease Business (2015-2020)
13.8.5 Cyclacel Pharmaceuticals Recent Development
13.9 Onconova Therapeutics
13.9.1 Onconova Therapeutics Company Details
13.9.2 Onconova Therapeutics Business Overview
13.9.3 Onconova Therapeutics Acquired Orphan Blood Disease Introduction
13.9.4 Onconova Therapeutics Revenue in Acquired Orphan Blood Disease Business (2015-2020)
13.9.5 Onconova Therapeutics Recent Development
13.10 Incyte Corporation
13.10.1 Incyte Corporation Company Details
13.10.2 Incyte Corporation Business Overview
13.10.3 Incyte Corporation Acquired Orphan Blood Disease Introduction
13.10.4 Incyte Corporation Revenue in Acquired Orphan Blood Disease Business (2015-2020)
13.10.5 Incyte Corporation Recent Development
13.11 CTI BioPharma
10.11.1 CTI BioPharma Company Details
10.11.2 CTI BioPharma Business Overview
10.11.3 CTI BioPharma Acquired Orphan Blood Disease Introduction
10.11.4 CTI BioPharma Revenue in Acquired Orphan Blood Disease Business (2015-2020)
10.11.5 CTI BioPharma Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Acquired Orphan Blood Disease Key Market Segments
Table 2. Key Players Covered: Ranking by Acquired Orphan Blood Disease Revenue
Table 3. Ranking of Global Top Acquired Orphan Blood Disease Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Acquired Orphan Blood Disease Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Medication
Table 6. Key Players of Bone Marrow Transplant
Table 7. Key Players of Blood Transfusion
Table 8. Key Players of Iron Therapy
Table 9. Global Acquired Orphan Blood Disease Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Acquired Orphan Blood Disease Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Acquired Orphan Blood Disease Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Acquired Orphan Blood Disease Market Share by Regions (2015-2020)
Table 13. Global Acquired Orphan Blood Disease Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Acquired Orphan Blood Disease Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Acquired Orphan Blood Disease Market Growth Strategy
Table 19. Main Points Interviewed from Key Acquired Orphan Blood Disease Players
Table 20. Global Acquired Orphan Blood Disease Revenue by Players (2015-2020) (Million US$)
Table 21. Global Acquired Orphan Blood Disease Market Share by Players (2015-2020)
Table 22. Global Top Acquired Orphan Blood Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acquired Orphan Blood Disease as of 2019)
Table 23. Global Acquired Orphan Blood Disease by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Acquired Orphan Blood Disease Product Solution and Service
Table 26. Date of Enter into Acquired Orphan Blood Disease Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Acquired Orphan Blood Disease Market Size by Type (2015-2020) (Million US$)
Table 29. Global Acquired Orphan Blood Disease Market Size Share by Type (2015-2020)
Table 30. Global Acquired Orphan Blood Disease Revenue Market Share by Type (2021-2026)
Table 31. Global Acquired Orphan Blood Disease Market Size Share by Application (2015-2020)
Table 32. Global Acquired Orphan Blood Disease Market Size by Application (2015-2020) (Million US$)
Table 33. Global Acquired Orphan Blood Disease Market Size Share by Application (2021-2026)
Table 34. North America Key Players Acquired Orphan Blood Disease Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Acquired Orphan Blood Disease Market Share (2019-2020)
Table 36. North America Acquired Orphan Blood Disease Market Size by Type (2015-2020) (Million US$)
Table 37. North America Acquired Orphan Blood Disease Market Share by Type (2015-2020)
Table 38. North America Acquired Orphan Blood Disease Market Size by Application (2015-2020) (Million US$)
Table 39. North America Acquired Orphan Blood Disease Market Share by Application (2015-2020)
Table 40. Europe Key Players Acquired Orphan Blood Disease Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Acquired Orphan Blood Disease Market Share (2019-2020)
Table 42. Europe Acquired Orphan Blood Disease Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Acquired Orphan Blood Disease Market Share by Type (2015-2020)
Table 44. Europe Acquired Orphan Blood Disease Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Acquired Orphan Blood Disease Market Share by Application (2015-2020)
Table 46. China Key Players Acquired Orphan Blood Disease Revenue (2019-2020) (Million US$)
Table 47. China Key Players Acquired Orphan Blood Disease Market Share (2019-2020)
Table 48. China Acquired Orphan Blood Disease Market Size by Type (2015-2020) (Million US$)
Table 49. China Acquired Orphan Blood Disease Market Share by Type (2015-2020)
Table 50. China Acquired Orphan Blood Disease Market Size by Application (2015-2020) (Million US$)
Table 51. China Acquired Orphan Blood Disease Market Share by Application (2015-2020)
Table 52. Japan Key Players Acquired Orphan Blood Disease Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Acquired Orphan Blood Disease Market Share (2019-2020)
Table 54. Japan Acquired Orphan Blood Disease Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Acquired Orphan Blood Disease Market Share by Type (2015-2020)
Table 56. Japan Acquired Orphan Blood Disease Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Acquired Orphan Blood Disease Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Acquired Orphan Blood Disease Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Acquired Orphan Blood Disease Market Share (2019-2020)
Table 60. Southeast Asia Acquired Orphan Blood Disease Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Acquired Orphan Blood Disease Market Share by Type (2015-2020)
Table 62. Southeast Asia Acquired Orphan Blood Disease Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Acquired Orphan Blood Disease Market Share by Application (2015-2020)
Table 64. India Key Players Acquired Orphan Blood Disease Revenue (2019-2020) (Million US$)
Table 65. India Key Players Acquired Orphan Blood Disease Market Share (2019-2020)
Table 66. India Acquired Orphan Blood Disease Market Size by Type (2015-2020) (Million US$)
Table 67. India Acquired Orphan Blood Disease Market Share by Type (2015-2020)
Table 68. India Acquired Orphan Blood Disease Market Size by Application (2015-2020) (Million US$)
Table 69. India Acquired Orphan Blood Disease Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Acquired Orphan Blood Disease Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Acquired Orphan Blood Disease Market Share (2019-2020)
Table 72. Central & South America Acquired Orphan Blood Disease Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Acquired Orphan Blood Disease Market Share by Type (2015-2020)
Table 74. Central & South America Acquired Orphan Blood Disease Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Acquired Orphan Blood Disease Market Share by Application (2015-2020)
Table 76. Acorno Acorns Company Details
Table 77. Acorno Acorns Business Overview
Table 78. Acorno Acorns Product
Table 79. Acorno Acorns Revenue in Acquired Orphan Blood Disease Business (2015-2020) (Million US$)
Table 80. Acorno Acorns Recent Development
Table 81. Alexion Pharmaceuticals Company Details
Table 82. Alexion Pharmaceuticals Business Overview
Table 83. Alexion Pharmaceuticals Product
Table 84. Alexion Pharmaceuticals Revenue in Acquired Orphan Blood Disease Business (2015-2020) (Million US$)
Table 85. Alexion Pharmaceuticals Recent Development
Table 86. Amgen Company Details
Table 87. Amgen Business Overview
Table 88. Amgen Product
Table 89. Amgen Revenue in Acquired Orphan Blood Disease Business (2015-2020) (Million US$)
Table 90. Amgen Recent Development
Table 91. Celgene Corporation Company Details
Table 92. Celgene Corporation Business Overview
Table 93. Celgene Corporation Product
Table 94. Celgene Corporation Revenue in Acquired Orphan Blood Disease Business (2015-2020) (Million US$)
Table 95. Celgene Corporation Recent Development
Table 96. Eli Lilly Company Details
Table 97. Eli Lilly Business Overview
Table 98. Eli Lilly Product
Table 99. Eli Lilly Revenue in Acquired Orphan Blood Disease Business (2015-2020) (Million US$)
Table 100. Eli Lilly Recent Development
Table 101. Sanofi Company Details
Table 102. Sanofi Business Overview
Table 103. Sanofi Product
Table 104. Sanofi Revenue in Acquired Orphan Blood Disease Business (2015-2020) (Million US$)
Table 105. Sanofi Recent Development
Table 106. GlaxoSmithKline Company Details
Table 107. GlaxoSmithKline Business Overview
Table 108. GlaxoSmithKline Product
Table 109. GlaxoSmithKline Revenue in Acquired Orphan Blood Disease Business (2015-2020) (Million US$)
Table 110. GlaxoSmithKline Recent Development
Table 111. Cyclacel Pharmaceuticals Business Overview
Table 112. Cyclacel Pharmaceuticals Product
Table 113. Cyclacel Pharmaceuticals Company Details
Table 114. Cyclacel Pharmaceuticals Revenue in Acquired Orphan Blood Disease Business (2015-2020) (Million US$)
Table 115. Cyclacel Pharmaceuticals Recent Development
Table 116. Onconova Therapeutics Company Details
Table 117. Onconova Therapeutics Business Overview
Table 118. Onconova Therapeutics Product
Table 119. Onconova Therapeutics Revenue in Acquired Orphan Blood Disease Business (2015-2020) (Million US$)
Table 120. Onconova Therapeutics Recent Development
Table 121. Incyte Corporation Company Details
Table 122. Incyte Corporation Business Overview
Table 123. Incyte Corporation Product
Table 124. Incyte Corporation Revenue in Acquired Orphan Blood Disease Business (2015-2020) (Million US$)
Table 125. Incyte Corporation Recent Development
Table 126. CTI BioPharma Company Details
Table 127. CTI BioPharma Business Overview
Table 128. CTI BioPharma Product
Table 129. CTI BioPharma Revenue in Acquired Orphan Blood Disease Business (2015-2020) (Million US$)
Table 130. CTI BioPharma Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acquired Orphan Blood Disease Market Share by Type: 2020 VS 2026
Figure 2. Medication Features
Figure 3. Bone Marrow Transplant Features
Figure 4. Blood Transfusion Features
Figure 5. Iron Therapy Features
Figure 6. Global Acquired Orphan Blood Disease Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Acquired Orphan Blood Disease Report Years Considered
Figure 11. Global Acquired Orphan Blood Disease Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Acquired Orphan Blood Disease Market Share by Regions: 2020 VS 2026
Figure 13. Global Acquired Orphan Blood Disease Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Acquired Orphan Blood Disease Market Share by Players in 2019
Figure 16. Global Top Acquired Orphan Blood Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acquired Orphan Blood Disease as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Acquired Orphan Blood Disease Revenue in 2019
Figure 18. North America Acquired Orphan Blood Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Acquired Orphan Blood Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Acquired Orphan Blood Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Acquired Orphan Blood Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Acquired Orphan Blood Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Acquired Orphan Blood Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Acquired Orphan Blood Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
後天性孤児造血疾患治療薬の世界市場（～2026年） Acquired orphan blood disease is a type of rare blood disorder, which occurs due to the presence of insufficient amount of red blood cells in the blood. This disease is characterized by the body’s inability to produce red blood cells. Moreover, improper functioning of bone marrow also leads to lack …- 院内感染症検査の世界市場（～2026年） Hosptial infection is categorized based on infection types into the following segments: blood stream infection (BSI) testing, urinary tract infection (UTI) testing, methicilin-resistant staphylococcus aureus (MRSA) testing, pneumonia testing, surgical site infection (SSI) testing & others infections…
- 希少疾患の世界市場（～2026年） An orphan disease is defined as a condition that affects fewer than 200,000 people nationwide. This includes diseases as familiar as cystic fibrosis, Lou Gehrig's disease, and Tourette's syndrome, and as unfamiliar as Hamburger disease, Job syndrome, and acromegaly, or "gigantism." Some diseases hav…
- 市中肺炎（CAP）の世界市場（～2026年） Community-acquired pneumonia (CAP) refers to pneumonia (any of several lung diseases) contracted by a person with little contact with the healthcare system. The market of CAP treatment and diagnosis in further segmented with respect to major geographies of North America, Europe, Asia-Pacific, and La…
- 医療関連感染（HAI）管理の世界市場（～2026年） A hospital-acquired infection (HAI), also known as a nosocomial infection, is an infection that is acquired in a hospital or other health care facility. The rise in the incidences of different types of hospital acquired infections, innovative technologies implemented in devices that control infectio…